60 related articles for article (PubMed ID: 3265361)
1. Fluorescence intensity of immunostained cells as a diagnostic aid in lymphoid leukemias.
Caldwell CW; Patterson WP
Diagn Clin Immunol; 1988; 5(6):371-6. PubMed ID: 3265361
[TBL] [Abstract][Full Text] [Related]
2. Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential.
Epstein AL; Marder RJ; Winter JN; Stathopoulos E; Chen FM; Parker JW; Taylor CR
Cancer Res; 1987 Feb; 47(3):830-40. PubMed ID: 3542194
[TBL] [Abstract][Full Text] [Related]
3. Use of the monoclonal antibody WR17, identifying the CD37 gp40-45 Kd antigen complex, in the diagnosis of B-lymphoid malignancy.
Moore K; Cooper SA; Jones DB
J Pathol; 1987 May; 152(1):13-21. PubMed ID: 3305845
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric expression of common antigens CD18/CD45 in blood from dogs with lymphoid malignancies: a semi-quantitative study.
Comazzi S; Gelain ME; Riondato F; Paltrinieri S
Vet Immunol Immunopathol; 2006 Aug; 112(3-4):243-52. PubMed ID: 16698089
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of monoclonal antibodies recognizing three distinct differentiation antigens (BL1, BL2, BL3) on human B lymphocytes.
Wang CY; Azzo W; Al-Katib A; Chiorazzi N; Knowles DM
J Immunol; 1984 Aug; 133(2):684-91. PubMed ID: 6429242
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody against a membrane antigen characterizing leukemic human B-lymphocytes.
Forster HK; Gudat FG; Girard MF; Albrecht R; Schmidt J; Ludwig C; Obrecht JP
Cancer Res; 1982 May; 42(5):1927-34. PubMed ID: 6175400
[TBL] [Abstract][Full Text] [Related]
7. [Flow cytometric analysis of malignant cells in lymphocytic leukemias and lymphomas by monoclonal antibodies].
Imamura N; Kuramoto A
Rinsho Ketsueki; 1988 Aug; 29(8):1227-36. PubMed ID: 3264587
[No Abstract] [Full Text] [Related]
8. Relationship between CD45 antigen expression and putative stages of differentiation in B-cell malignancies.
Caldwell CW; Patterson WP
Am J Hematol; 1991 Feb; 36(2):111-5. PubMed ID: 1849347
[TBL] [Abstract][Full Text] [Related]
9. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.
Epstein AL; Marder RJ; Winter JN; Fox RI
J Immunol; 1984 Aug; 133(2):1028-36. PubMed ID: 6376628
[TBL] [Abstract][Full Text] [Related]
10. Three distinct antigen systems on human B cell subpopulations as defined by monoclonal antibodies.
Takami T; Ishii Y; Yuasa H; Kikuchi K
J Immunol; 1985 Feb; 134(2):828-34. PubMed ID: 3917477
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte gating of peripheral blood in patients with leukemic low-grade non-Hodgkin's lymphoma by multiparametric flow cytometry.
Höffkes HG; Schmidtke G; Schmucker U; Brittinger G
Eur J Med Res; 1996 Jan; 1(4):215-22. PubMed ID: 9445762
[TBL] [Abstract][Full Text] [Related]
12. The application of monoclonal antibodies to the characterization and diagnosis of lymphoid neoplasms: a review of recent studies.
Knowles DM; Dodson LD; Raab R; Mittler RS; Talle MA; Goldstein G
Diagn Immunol; 1983; 1(3):142-9. PubMed ID: 6333955
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody studies in B(non-T)-cell malignancies.
Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
[TBL] [Abstract][Full Text] [Related]
14. [Determination of leukemic B-lymphoma cells with the monoclonal antibody anti-Y 29/55].
Obrecht JP; Gudat F; Forster HK; Albrecht R; Girard MF; Ludwig C; Christen C
Schweiz Med Wochenschr; 1981 Oct; 111(41):1529-31. PubMed ID: 6975994
[TBL] [Abstract][Full Text] [Related]
15. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
[TBL] [Abstract][Full Text] [Related]
16. [Immunophenotyping of haematologic malignancies].
Koehorst SG; Evers H; van Buul T; de Vries F; Haanen C
Ned Tijdschr Geneeskd; 2004 Sep; 148(38):1861-5. PubMed ID: 15497779
[TBL] [Abstract][Full Text] [Related]
17. The CD45 isoform B220 identifies select subsets of human B cells and B-cell lymphoproliferative disorders.
Rodig SJ; Shahsafaei A; Li B; Dorfman DM
Hum Pathol; 2005 Jan; 36(1):51-7. PubMed ID: 15712182
[TBL] [Abstract][Full Text] [Related]
18. SC3 monoclonal antibody defines a novel specific human B-cell surface antigen differentially expressed on B-cell leukaemias and lymphomas and involved in the proliferation of normal and malignant B lymphocytes.
Nikolova M; Guenova M; Taskov H; Marie-Cardine A; Boumsell L; Bensussan A
Cell Immunol; 2005; 236(1-2):92-100. PubMed ID: 16197933
[TBL] [Abstract][Full Text] [Related]
19. B-cell malignancies and differentiation antigens defined with monoclonal antibodies.
Kikuchi K; Koshiba H; Kasai K; Hiratsuka H; Fujimoto N; Uede T
Jpn J Clin Oncol; 1983 Sep; 13(3):517-31. PubMed ID: 6417375
[TBL] [Abstract][Full Text] [Related]
20. CD2 is expressed by a subpopulation of normal B cells and is frequently present in mature B-cell neoplasms.
Kingma DW; Imus P; Xie XY; Jasper G; Sorbara L; Stewart C; Stetler-Stevenson M
Cytometry; 2002 Oct; 50(5):243-8. PubMed ID: 12360573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
